DeFriend D J, Klimack O E, Humphrey C S, Schraibman I G
Department of General Surgery, Birch Hill Hospital, Rochdale, England.
J R Soc Med. 1997 Mar;90(3):132-5. doi: 10.1177/014107689709000305.
Intraluminal stenting of the small bowel has been advocated as a method of reducing the risk of recurrent adhesional obstruction in patients requiring adhesolysis. We reviewed the complications and efficacy of this technique in 25 patients undergoing surgery for relief of intestinal obstruction due to complex, extensive and dense adhesions. Five patients developed minor and three patients major complications. Three (13%) of 23 patients alive after mean follow-up of 4 years had had episodes of recurrent intestinal obstruction, but none had required reoperation. Intraluminal stenting remains of unproven efficacy. It may find a place as an adjunct to adhesolysis in patients requiring repeated operations for the relief of obstruction due to extensive and dense adhesions; but, in view of the high rate of complications, careful case selection will be necessary.
小肠腔内支架置入术已被提倡作为一种降低需要粘连松解术的患者复发性粘连性肠梗阻风险的方法。我们回顾了该技术在25例因复杂、广泛和致密粘连而接受手术以缓解肠梗阻的患者中的并发症和疗效。5例患者出现轻微并发症，3例患者出现严重并发症。23例患者在平均随访4年后存活，其中3例（13%）发生复发性肠梗阻，但均无需再次手术。腔内支架置入术的疗效仍未得到证实。对于因广泛和致密粘连而需要反复手术以缓解梗阻的患者，它可能作为粘连松解术的辅助手段占有一席之地；但是，鉴于并发症发生率较高，需要仔细选择病例。
